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INTRODUCTION

This thesis explores the pathological and clinical presentation
of polycystic disease and their correlation with the findings available
during intravenous urography.
Polycystic disease of the kidneys

(adult type) is a familiar and

congenital pathological disorder transmitted through an autosomal domi¬
nant mode of inheritance.

It is characterized by variable expressivity

of the gene(s) with virtually 100% penetrance, if the patient survives
into the ninth decade.

Involvment is usually bilateral and pregres-

sive; with the onset of symptons,

the patient pursues an inexorable

downhill course leading to uremia and death in the absence of operative
intervention with renal transplantation.
Polycys tic disease is characterized by irregularly shaped cysts
of nephronic origin located diffusely throughout the cortical and medul¬
lary regions of the renal parenchyma with intervening areas of normal
or minimally fibrotic renal tissue.

There is a high incidence of asso¬

ciated cystic involvment of other viscera, principally the liver and
spleen, cerebral aneurysm and erythrocythemia.
42, 49,

60, 65,

72,

83)

(4,

17, 18,

20,

21,

31,
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PART ONE:

PATHOLOGY

GROSS PATHOLOGY

On visual inspection, polycystic kidneys are almost always enlarged
and may attain weights of seven or eight kilograms and measure as much as

43 to 48 centimeters.

(31)

The degree of enlargement varies according

to the number of nephrons evidencing cystic involvement and according to
the volume of fluid accumulating within the cysts

(29 ,60); generally,

the degree of cystic change is related to the age of the patient (17,

31).

Enlargement may proceed asynchronously leading to marked asymmetry of
the two involved kidneys.
Although disagreement exists about the existence of unilateral poly¬
cystic disease, involvement is usually bilateral.

Bell (4)

reported a

unilateral incidence of 8%, by far the highest reported in the pathology
literature; by contrast, Narins and Oppenheimer (50)

contend that it is

rare to encounter an adult with unilateral disease.

In those cases of

reported unilateral disease,

the contralateral kidney has been described

as either aplastic or hypoplastic.

(4, 17, 29 , 50, 59 , 70)

Two cases

of polycystic disease in solitary kidneys have been reported and these
underwent compensatory hypertrophy resulting in clinical courses similar
to that of relatives with two kidneys.

(3)

Polycystic kidneys usually present as normally shaped kidneys al¬
though increased proportionally in size.

The outer surface of the kidney

is irregular and nodular, studded with translucent vesicles of varying
size bulging from the capsular surface.

The capsule of the kidney usually

is unchanged although it may adhere firmly to the kidney surface and be
difficult to strip.

Examination of the cut surface reveals oval or spher¬

ical cysts filled with thin colorless fluid involving both the renal cortex

and medulla.

The cysts vary in size from the microscopic up to four to

five centimeters.

If there has been hemorrhage into a cyst,

the fluid

may be thickened and may shade in color from bright red to brown.

Usually

cysts are more numerous and more tightly packed in the cortex, often
abutting one another and separated by only a single layer of epithelial
cells.

A medullary cyst may bulge into the renal pelvis.

The normal

architecture of the kidney is disturbed; papillae are often absent and
the kidney is seldom divided into normal pyramids.

(4, 11,

17,

29,

31,

60)

The most frequent renal lesions associated with polycystic disease are
hydronephrosis and pyonephrosis
ureter by a lower pole cyst],

[usually secondary to compression of the

and pyelonephritis.

(34)

McNamara (47) in

a series of twenty five post-mortem examinations reported a 57% incidence
of pyelonephritis in patients with polycystic disease.

Tumors and cal-

culosis are less common associations.

the ureters, blad¬

(31)

der, and urethra are free of involvment.

Generally,

(29)

HISTOPATHOLOGY

The microscopic appearance of the .kidney is generally consonant
with the degree of cystic involvment evident on gross inspection of the
kidney, the mildest changes being found in those kidneys with a relatively
normal gross appearance.

(60)

Destruction of nephrons may be due to

progressive cystic dilatation of a component structure, compression of
normal adjacent tissue by enlarging cysts leading to pressure atrophy
and fibrosis, hemorrhage, and infection.

(47,

60)

In their classic microdissection studies of polycystic kidneys,
Osthanondh and Potter (60) discovered that cysts may be found in any por¬
tion of the nephron and collecting duct, most commonly at the angle of the
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loop of Henle and Bowman's space; however, any individual case may dis¬
play a preferential involvment for a given structure.
are multipolar and communicate with the

As a rule, cysts

collecting system of the kidney.

Glomerular cysts usually arise from a dilatation of Bowman's capsule.
Glomerular tufts may be small and incompletely vascularized with capil¬
lary loops either separated by large amounts of hyalinized connective
tissue or, in occasional specimens, scattered along the inner wall of
the cyst.

Individual or groups of tubules may dilate forming thin-

walled cysts and demonstrate diffuse or saccular enlargment of the
proximal tubule,

the descending and ascending limbs of the loop of Henle,

the distal tubule, or at the junction of the distal tubule and the col¬
lecting duct.

(41,

60)

Cysts of collecting tubules are generally larger

than those of the~nephrons and are surrounded by a thick zone of com¬
pact connective tissue.

(60)

Cyst walls may be lined discontinuously

with cuboidal or flattened epithelium; proximal tubular cysts often
are lined by characteristic eosinophilic pyramidal cells with a recog¬
nizable brush border.

(29)

There is a fundamental disorder in the organization of the renal
architectureDuring organogenesis, individual tubules of the metanephric
blastema may divide asynchronously so that the architecture of minor
calyces, papillae and pyramids may be quite different in different parts
of the kidney.

(60)

Nephrons may attach irregularly to the collecting

tubules resulting in a failure to form normal papillae and pyramids.
Attachment of several nephrons to the end of a single collecting tubule
result in pseudopapilla formation.

Arcades may be absent when nephrons

attach to collecting tubules proximal to the last generation.

(60)

Blood

vessels are of irregular size and distribution; interlobular arteries
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frequently course beneath cyst walls composed of a single layer of
epithelium leading to considerable hemorrhage with arterial rupture.

(31)

Arterioles may be involved by a sclerosing process giving rise to
thickened walls and narrowed lumens.

(31, 60)

Nerve trunks often de¬

monstrate increased prominence.

ASSOCIATED ABNORMALITIES

The most commonly associated abnormality of polycystic kidney
disease is polycystic liver disease.

The reported association in the

pathology literature varies from 16% (17)
monly accepted figure, however, is 33%.

to 73%

(83); the most com¬

(14, 29, 65)

Conversely, the

association of polycystic involvment of the kidneys in patients with a
primary diagnosis of polycystic liver disease is 50%.

(14)

Other cystic

disorders associated with polycystic kidney disease are polycystic pan¬
creas, approximately 10% (29, 65), spleen, 2% to 5% (29,

65), and rarely,

thyroid, ovary, endometrium, seminal vesicle, epididymus, esophagus, and
cerebellum.

(17, 29, 31)

Significant clinically, there is a high association (15%) of
aneurysm of the basal arteries of the brain with polycystic disease;
the anterior half of the circle of Willis is the most frequent location
of these aneurysms.

(17, 29)

Conversely,

3.5% of patients with intra¬

cranial aneurysm have associated polycystic disease.

ETIOLOGY AND PATHOGENESIS

Numerous theories have been advanced describing the pathogenesis
of polycystic disease; none is adequate to explain fully the disease and

6

its associations.

They may be divided into four general classes:

the

embryogenic; the metabolic; the neoplastic; and, the inflammatory.
embryogenic theories of Hildebrand
the most wide-spread acceptance.

The

(30) and Kampmeier (38, 48) have gained
Hildebrand postulates that the condi¬

tion arises from a derangement in the union

of the dual anlagen of the

developing kidney; a failure of the union of the ureteric bud with the
metanephric blastema deprives the primitive nephrons of an organizing
influence giving rise to disturbed renal architecture and cyst formation.
Kampmeier proposes that the disease has its origins in a disturbance in
the normal processes of division and involution; thus, there is a failure
of involution of the first generation of nephrons to differentiate in
the metanephrons with eventual cystic degeneration.

Potter (60) echoes

Hildebrand suggesting that there is a failure of coordination in the
patterns of division of the collecting tubules, deriving from the ureteric
bud, and the nephrons and connective tissue, deriving from the metanephric
blastema.

The metabolic theories (18, 61,

72) adduce a toxic metabolite

from experimental preparations with cystic disease induced by exogenously
administered agents.

Additional support for this theory is lacking in

that, as yet, there have been no reported cases of polycystic transforma¬
tion of a kidney transplanted into a patient suffering from polycystic
disease of his own kidneys.

[There has been a considerable transplant

experience in polycystic disease; the last three reports of the Human
Transplant Registry

(76,

77, 78) indicate that approximately 5% of renal

transplants performed annually have been for the treatment of polycystic
disease.]

The neoplastic theories (17, 33) attribute the disease to

hamartomas or cystic adenomas of the renal substance.

Finally,

the in¬

flammatory hypotheses attribute cyst formation to a variety of insults to
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the kidney:

papillitis (31), arterial ruptures into the substance of

the kidney (35), and tubular occlusion resulting in multiple retention
cysts (17).

INCIDENCE

Estimates of the incidence of polycystic disease vary widely be¬
tween clinical and autopsy data, but indicate, that there is widespread
failure to recognize the disease ante-mortem.
are equally involved,

TABLE 1:

[Table I]

Men and women

the disease demonstrating no sex predominance.[Table 2]

CLINICAL AND AUTOPSY INCIDENCE OF POLYCYSTIC
DISEASE OF THE KIDNEYS

SURVEY
1. Mt. Sinai Hospital,
New York City
2. Mayo Clinic
3. Jewish Hospital,
Brooklyn, N.Y.
4. London Hospital,
London, England
5. University of
Minnesota
6. Nauman
7. Cleveland Clinic
8. Dalgaard Denmark
(17)
9. Bell (4)
10. Simon and Thompson (22)

DIAGNOSIS
ON CLINICAL
CRITERIA

1:3,666
1:3,524

DIAGNOSIS
BY AUTOPSY

1:
428
1:1 ,019
1:

158

1:
1:

509
650

1:
1:
1:

773
351
323

1:4,800

1:4,000

1:2,438

after Higgins (31)

Symptans

of the "adult form" of the disease may appear at any age; how¬

ever, it presents most frequently in the fourth or fifth decades of life.
[Table 3]
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TABLE 2:

CLINICAL INCIDENCE OF POLYCYSTIC DISEASE IN MEN
AND WOMEN
NUMBER
OF WOMEN

NUMBER
OF MEN
Dalgaard (17)
Simon and Thompson (72)
Rail and Odell (65)

TABLE 3:
AGE (in years)
AT DIAGNOSIS

350
366
207

193
163
113

157
203
94

AGE OF CLINICAL INCIDENCE OF POLYCYSTIC DISEASE
DALGAARD (17)
WOMEN
MEN

RALL AND
ODELL (65)

SIMON AND
THOMPSON (72)

3%

2.5%

0-9
10-19

0.6%
0.5%
(15-19 years)
6.8
4.4
23.0
22.9
27.9
29.9
24.8
25.4
11.5
11.4
5.2
3,8
1.9

20-29
30-39
40-49
50-59
60-69
70-79
80-84

PART TWO:

TOTAL

1
9
34
27
20
6 [ greater
than 60
yrs. of age]

1.1
8.7
22.4
34.2
22.4
6.8
1.9

CLINICAL FEATURES

CLINICAL PRESENATION

The diagnosis of polycystic disease is a challenge to the clinician.
The clinical picture is often misleading depending upon the stage at which
the patient presents for diagnosis; none of the signs or symptoms is patho¬
gnomonic.
The onset of the disease is usually insidious;

the patient may be

unaware until routine physical examination and laboratory analysis dis¬
close renal enlargement, hypertension, proteinuria, microscopic hematuria,
or evidence of asymptomatic urinary tract infection.

(17)

Simon and
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Thompson (72) report that 133 of 366 patients in their series had no
symptons referable to polycystic disease at the time of diagnosis.
The clinical history is invaluable in the diagnosis.

Polycystic

kidney disease is an autosomal dominant hereditary disease with variable
penetrance and expressivity.

(17,

18, 20, 62, 83)

There is virtually

100% penetrance if the patient survives into the ninth decade of life.
[vide supra]

Despite this, reports of a positive family history range

from 18%, in a series of 366 by Simon and Thompson (72), to 36%, in a
series of 94 cases compiled by Higgins (31).

The classic

presentation

is of a middle-aged person with a positive family history and symptons
referable to early renal failure.

(63)

[ Table 4]

As in the case of

most classic presentations, this constellation is encountered infrequently.

TABLE 4:

Cases

PER CENT INCIDENCE OF CLASSIC FINDINGS IN POLYCYSTIC KIDNEY DISEASE

Rail and
Odell
(65)
207

Simon and
Thompson
(72)
366

Daalgard
(17)

Higgins
(31)

350

94

Ward, Draper,
and Lavengood
(83)
53

—

45
59
46

36
41
64
73

32
47
47
62

FINDING
Family history
(positive)
Gross Hematuria
Abdominal pain
Hypertension
Palpable kidneys
(one or both)
Elevated blood
urea nitrogen

34
48
28
73

18
31
44
55

72

78

61

80

73

36

44

44

70

45
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Pain is the cardinal presenting
medical assistance.

(17,

31, 65,

symptom for which a patient seeks

72, 83)

Most commonly, he complains of

a dull nagging ache or pressure in the flank.

The pain is usually uni¬

lateral, may be intermittent or continuous, and may be so persistent and
severe as to be disabling.

(17,

31, 65,

72,

83)

The pain may result from

the excessive weight of the kidney producing tension on the renal pedicle,
hemorrhage within a cyst, or the mechanical pressure of expanding cysts on
adjacent organs.

(72)

The reported incidence of flank or abdominal pain

ranges from 28% (65) to 64% (31).

[Table 4]

Acute renal colic is unusual,

but may occur with the passage of a clot down the ureter.

(72)

Loin

pain radiating to the back, chest, epigastrium, or groin may also be en¬
countered.

Complaints of pain usually occur early in the course of the

disease.
Gross hematuria is the second most common complaint.

[Table 4]

Hematuria is usually self-limited, of short duration, episodic, and sel¬
dom heavy enough to cause exsanguination.

It is precipitated in most

instances by trauma or unusual physical exertion.
persistent, it may be associated with anemia.

(83)

(17,

31,

72,

83)

If

Bell (4) and Simon

Thompson (72) assert that over the course of their disease, between one
third and one half of patients will develop hematuria.

Appearance of

gross bleeding shows no sex predominance and usually appears in the mid¬
dle of the disease’s course.

(17)

There is an unusually high incidence of urinary tract infection in
polycystic disease suggestive of an increased susceptibility to bacterial
invasion.

(17)

[vide infra]

nary tract infection:
(72)

to 69%

(31).

The reported incidence of symptomatic uri¬

frequency, dysuria,

fever, chills; ranges from 21%

In Rail and Odell's series (65), 20% of patients presented to
renal clinic following the discovery of renomegaly, either by themselves
or the referring physician.

On physical examination, renal enlargement

was found bilaterally in 51% to 60% of cases and unilaterally in 13% to
25% of cases, with an unexplained predominance of left sided enlargement
with unilateral physical findings.

(17, 31,

65, 72, 83)

Occasionally,

enlargement may occur to the point of causing visible distention of the
abdominal wall and an increase in the circumference of the abdomen.(17)
Hypertension is a frequent physical finding during the course of
polycystic disease and not infrequently is the first sign detected in
the disorder.

Rail and Odell (65) found that the initial finding of

hypertension led to the diagnosis in 16% of their polycystic population;
furthermore, they found a 35% incidence of hypertension during the initial
visit for the evaluation of the disease.

Disparity in the time course at

which a patient presents for diagnosis may account for the variations in
the incidence of hypertension [35% (65, 72)

to 62% (83)] during that

initial visit.

CLINICAL COURSE AND LABORATORY DATA

Cysts present at birth (20, 31, 41, 60,

62) remain asymptomatic

through the patient's early decades allowing him to pursue a normal life.
Symptoms may appear as early as the second decade (17), but these are
generally well tolerated until the fourth or fifth decade; as the cysts
enlarge and renal function deteriorates the patient seeks medical atten¬
tion.

(17, 31, 65, 72, 83)

[Table 3]

When the disease first manifests

itself in later life, it pursues a more virulent downhill course, with
death from hypertension and its sequelae or uremia within a few years.
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(17, 31, 83)

Survival following the onset of symptoms is usually less

than ten years.

(27)

Patients with the disease enjoy a shorter life ex¬

pectancy than the general population.

Simon and Thompson (72) compared

the five and ten year survival of normal and polycystic populations.

They

found that the unwolved group, at age 44 years, had a five year survival
rate of 96% and a ten year survival of 90.5%; this compared sharply with a
survival rate of 56% and 38%, respectively, in the polycystic group.

Post¬

diagnosis, eleven of their 366 cases survived more than twenty years, and
Dalgaard (17) reported one thirty five year survivor.
Many patients will remain asymptomatic into the seventh and eighth
decades, and polycystic disease may be an incidental finding at autopsy.
(4, 17, 31)

In their post-mortem series of fifty eight patients with

polycystic kidney disease and concomitant polycystic involvement of the
liver, Hatfield and Pfister (27)

found wide discrepancies between the group

of patients who were asymptomatic at the time of death and the symptomatic
group and question whether polycystic kidney disease is an unified diag¬
nostic estity.

To summarize their findings:

the average age at the time

of death for the asymptomatic group was 73.0 years.
of their kidneys was 512 grams
155 grams in females].

[normal:

The combined weight

125 to 170 grams in males; 115 to

One fifth of these patients had at least one cyst

greater than three centimeters.

The group of patients who were sympto¬

matic ante-mortem averaged 51.8 years at the time of death.

Their kidneys

weighed 930 grams, and one half had at least one cyst larger than three
centimeters.
largement.

Both groups had an equal incidence of asymmetric renal en¬
Rather than representing two distinct entities, these findings

may also be interpreted as consistent with a hereditary disease of variable
expressivity.
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Polycystic kidneys may be involved by any of the acquired renal
diseases.

Inflammatory complications include such entities as pyelitis,

pyelonephritis, and paranephritis.

(17)

The reported incidence of uri¬

nary tract infection may approach 65% with problems of recurrence in
approximately 11% of cases.

(17, 31, 65, 72, 83)

[Table 4]

The most

commonly associated pathogens are E. Coli, P. vulgaris, Staph, albus, and
Str. faecalis.

(31)

Mac Namara (47) examined the kidneys of twenty three

patients with polycystic disease who came to necropsy for evidence of
pyelonephritis.
teen patients

He found evidence of infection in the kidneys in thir¬

[57%], eight of whom [35%] had evidence of extensive infec¬

tion involving more than 50% of the kidney.

Of these thirteen patients,

only four were expected to have pyelonephritis ante-mortem.

Malignancy

is rarely associated with polycystic disease; there are fewer than twenty
five cases reported including one case each of intracystic papilloma,
fibrosarcoma, and angiomyosarcoma.
43, 46, 50, 51,

64, 67,

71, 75,

(2, 8, 9, 10, 13, 15, 17, 28,

79, 81)

32,

36,

The problems of diagnosis in a

kidney with an already deformed gross structure are obvious, and, in most
cases, malignancy was not expected prior to surgical exploration or necropsy.
The relentless cystic conversion of the kidneys leads to progressive
renal insufficiency in the majority of cases.

(17,

31, 72)

Dalgaard (17)

noted that within a family, the pattern of deterioration had a certain
uniformity.

Early in the clinical course, urinalysis, renal function tests

and serum chemistries are of little value in the assessment of the disease
(31); cystic nephrons retain their function and contribute to the functional
capacity of the kidney.

(11, 17, 41)

Normotensive patients with uremia

may remain stable for many years, but with the supervention of uncontrolled
hypertension, the patient pursues a rapid and inexorable downhill course.

(27)
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Rail and Odell (65) reported that following the onset of azotemia [BUN•>
40 mg/100ml.] the average life expectancy was 2.2 years.
Serial examination of patients demonstrate that four fifths will
develop hypertension during their clinical course
all will be hypertensive pre-terminally.

(83)

(31, 65, 72); nearly

Hypertension in combina¬

tion with cerebral aneurysm or renal failure augurs an ominous turn in
events; these patients have an average life expectancy fifteen years shorter
than normotensive patients with aneurysm or azotemia.

(27)

Despite uremia and recurrent hematuria, polycystic patients are
able to maintain hemoglobin levels in excess of 11 gm/100 ml.

(31, 65,

72)

Polycystic patients who come to dialysis tolerate the procedure better
than other uremic patients; they require fewer transfusions to maintain
their hematocrits.

(42)

In rare instances, polycystic disease has been

associated with frank polycythemia vera.
tive erythrocytosis during dialysis
both corrected by nephrectomy.

(12, 24, 25,

37,

73)

The rela¬

(42) and frank pdycythemia (73) are

No studies, to date, have been published

correlating levels of erythropoietin with erythrocytosis in these patients.
The association suggests that a combination of uremia and high or normal
levels of hemoglobin may lead to an unsuspected diagnosis of polycystic
disease in the patient with renal failure.
Leading causes of death in polycystic disease are uremia, myocar¬
dial infarction, cerebro-vascular accident and cardiac decompensation
secondary to hypertensive cardiovascular disease.

TABLE 5:

(72)

[Table 5]

LEADING CAUSES OF DEATH IN POLYCYSTIC KIDNEY DISEASE

Terminal Event
Uremia
Cardiac disease
Cerebral hemorrhage

Dalgaard (17)
59%
6
13

Rail and Odell (65)
20%
13
9

Higgins
66%
—-

(31)
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With the advent of hemodialysis, renal transplantation and neph¬
rectomy,

the natural history of polycystic disease has been altered^, im¬

proving the long term prognosis.

(1, 5, 42, 63,

69)

Lazarus and his

co-workers (42) have reported considerable success in the control of hyper¬
tension with dialysis.

All their patients suffered from symptomatic

uremia at the time at which dialysis was instituted; they reported no
unusual complications from the procedure.
throcytosis of polycystics

Because of the relative ery-

[vide supra] they discourage routine nephrec¬

tomy except in cases with uncontrolled hematuria or life threatening sepsis.
The results of renal transplantation were.also encouraging provided that
transplant recipents were first stabilized on hemodialysis and that the
graft survived for at least six months.

Pre-transplant nephrectomy has

been advised to obviate the mechanical problems during surgery from grossly
enlarged kidneys, for control of upper urinary tract infection, hyperten¬
sion and vesico-ureteral reflux.

(68)

RADIOLOGY

Radiographic diagnosis of polycystic disease becomes feasible with
the progression of the disease to gross involvement.

During the early

course of the disease, radiologic changes are minimal and may pass unde¬
tected.

Diagnostic accuracy is increased and earlier detection of changes

made possible through the use of special study techniques such as retro¬
grade pyelography (31, 72), infusion pyelography (27, 68, 83), nephro¬
tomography (17,

23, 26, 33), and renal angiography (7, 12, 16,

20, 22, 49)

On the plain film of the abdomen, large irregular renal outlines
are suggestive of polycystic involvement.

The kidneys have an embossed

outline and are usually longer than fourteen centimeters.

When the kid¬

neys are not visualized on the plain film, displaced loops of bowel are
suggestive of enlargement.

(7, 17, 21, 22, 40)

With advancing age of

the patient, the degree of enlargement increases.

Thus, enlargement is

found in 11% of patients at age 35 years, 50% at age 50, and 74% at age
75.

(17)
Visualization of the renal parenchyma and collecting system with

the use of contrast materials allows further delineation of polycystic
involvement.

[Figure 1]

During the latent phase of the disease small

radiolucencies which correspond to areas of cystic involvement produce a
non-homogenous nephrogram; in the presence of normal renal function, the
nephrogram may be assessed during the first three minutes of urography.
During nephrotomography (12, 23, 33) or infusion tomography (27, 83)

(26)

[in

patients with BUN > 40 mg.%] visualization of cysts as well-demarcated,
thin-walled, sharp radiolucencies in the midst of normally functioning
areas of parenchyma give rise to a characteristic moth-eaten appearance.
The renal calyces appear elongated and crescentic.

Impinged upon by cysts

of varying sizes, they are often described as "spidery".
72, 83)

(7, 17,

20, 31,

This must be differentiated from the "spider-leg pelvis", a

normal variant.

(21)

Because of intervening cysts, the renal parenchyma

appears thickened (21); measuring greater than three centimeters from the
most laterally projecting calyx to the margin of the kidney
(7, 17)

[normal:

2.7 cm.

The longitudinal axis of the kidney shifts from its normal posi¬

tion parallel to the spine.

(7, 17)

Multiple cystic impressions impinge

upon the renal pelvis which may be shifted laterally due to the enlarge¬
ment of parenchyma medial to it.

(7)

The pelvic ampulla assumes a horn

shape; since this is also a normal variant this sign is useful only as
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Fig. 1.

Intravenous Pyelographic Findings in Adult Polycystic

Disease of the Kidneys.
A.

Right Kidney:
Urogram demonstrates elongated spidery calyces, sculpted
by numerous cysts.
Large lower pole cyst extends from L-3 to iliac crest.
The longitudinal axis of kidney is displaced shifted nearly parallel to
spine.

1 B.

Detail of right kidney; Lateral margin and most laterally projecting
calyx:
Demonstrating attenuation of calyceal system.
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1 C.

Left kidney:
Urogram demonstrates knobby, irregular renal outline.
The calyceal system is sculpted by numerous cysts.
The longitudinal
axis of the kideny is shifted parallel to spine.

20

1 D.

Detail of left kidney; lateral margin of kidney and most laterally
projecting calyx:
The calyx is indented by a cystic impression.
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further confirmatory evidence in the diagnosis.

(7)

Lowman and Haber (44)

recommend simultaneous hepatonephrotomograph in order to detect any co¬
existing cystic disorder of the liver.
Because of the risk of ascending infection, instrumentation of
the upper urinary tract must be approached with caution.

(17)

Retro¬

grade pyelography provides more complete visualization of the collecting
system and may increase the diagnostic accuracy in the case of inadequate
intravenous urography.

(72)

The findings on retrograde examination are

similar to those described above.

(17, 31, 49,

72)

Angiography is the most discriminating tool in the radiographic
analysis of polycystic kidneys.

(7, 16, 22, 49)

During the nephrogenic

phase, the kidneys assume the characteristic moth-eaten appearance.
21, 22, 49)

(7, 20,

The arterial phase may reveal deformed, partially atrophic

vessels, with displacement of the interlobular and segmental arteries by
large cystic masses.

(88)

The volume of the renal parenchyma may be

estimated from the relative size of the renal outline and its arterial
tree; a small arterial system supplying a large kidney mass indicates a
significant loss of parenchyma.

(49)

In a series of twenty three patients reviewed by Hatfield and
Pfister (27), intravenous pyelography proved diagnostic of polycystic
disease in eight patients, suggestive of the disease, but not diagnostic
in another fourteen and interpreted as within the limits of normal in one
case.

Unilateral changes were present in seven patients all of whom

evidenced bilateral disease at autopsy.

In eleven cases where retrograde

pyelography was performed, the examinations were diagnostic in three.
were encouraged by the results of infusion tomography, obtaining

They

the

diagnosis in three cases studied in this way, and recommended it as the
study of choice for evaluation of the suspected case of polycystic disease.
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TABLE 6:
I. On
A.
B.

RADIOGRAPHIC FINDINGS IN POLYCYSTIC KIDNEY DISEASE
Plain Film of the Abdomen
Large renal outlines:
length greater than 14 cm.;
with possible displacement of bowel.
Embossed outline

II. Intravenous Pyelogram
A.
Parenchymal thickening:
greater than 3 cm.
B.
Elongation of the renal pelvis:
greater than 9 cm.
C.
Elongation of calyces.
D.
Crescentic, spidery calyces.
■I
E.
Multiple impressions of cysts in the renal pelvis.
F.
Lateral displacement of the pelvis.
G.
Longitudinal axis of the kidney parallel to the spine.
III. Nephrotomography
A.
Moth-eaten appearance during nephrogram phase.
B.
Well circumscribed radiolucencies surrounded by nor¬
mally opacified parenchyma.
IV. Renal Angiography
A.
Moth-eaten appearance during nephrogenic phase.
B.
Well circumscribed radiolucencies surrounded by nor¬
mally opacified parenchyma.
C.
Deformed, partially atrophic vessels.
D.
Displacement of interlobular and segmental arteries.

Ultrasound offers the possibility of early diagnosis, before the
characteristic roentogenographic changes appear on intravenous urography.
Lufkin, et. al.

(45) studies sixty four patients in a kindred for evidence

of polycystic disease.

Thirty one patients displayed sonographic evidence

of the disease; only fifteen of these evidenced changes on intravenous pye¬
lography.

DIFFERENTIAL DIAGNOSIS

The major problem in the differential diagnosis of polycystic
disease is the distinction of the condition from renal neoplasm.

Presen¬

tation of a patient with non-specific symptoms referable to the kidney,
renal enlargement on plain film of the abdomen or intravenous urography,
and, perhaps, some compromise of renal function immediately raise the
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specter of renal neoplasm.

The most useful reontgenographic technique

used to distinguish cystic enlargement from the malignant, is renal angio¬
graphy.

(7, 12, 49)

During the arterial phase of an angiogram, a neo¬

plasm demonstrates a confluence of irregular, small vessels or a puddling
of contrast material in the region of the lesion,

the "tumor blush"; dur¬

ing the nephrogenic phase, a malignant lesion has a radiographic density
equal to or greater than that of the surrounding renal parenchyma, and
may show areas of necrosis.

(12)

A cystic lesion demonstrates an avas¬

cular space occupying lesion during the arterial phase, and one or more
round or ovoid lucencies which are well marginated by the surrounding nor¬
mal parenchyma during the nephrogenic phase.

(12)

Ultrasound has also

been used successfully to differentiate cystic from solid space occupying
lesions within the kidney.

(45)

Because of the prognostic implications and the need for accurate
counseling, polycystic disease must be distinguished from other cystic
disorders of the kidney.

[Table 7]

Cystosis may cause renal enlargement

detectable on physical examination, and a radiographic picture similar to
polycystic disease.

(17)

A diagnosis of retention cysts of the kidney

carries little promise of progressive renal functional impairment.
cysts may be single, multiple, multilocular or hemorrhagic.

Simple

A kidney with

multiple simple cysts may be differentiated from polycystic disease be¬
cause it is usually unilateral, causes less destruction of the renal paren¬
chyma, and is non-hereditary.

(17, 74)

On physical examination, a kidney

with multiple cysts may be palpably enlarged, and, radiologically the in¬
volved kidney may resemble the polycystic kidney.

Pyelogertic (peripelvic)

cysts are usually adjacent to the renal pelvis, communicating directly
through a calyx.

A parapelvic cyst is adjacent to the pelvis, but lacks

direct communication.

These two entities may cause lateral deviation of
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the renal pelvis, one of the roentgenographic signs of polycystic disease.
Kidney cysts may also arise secondary to the variety of pathologic processes
of the kidney such as calculosis,
tis, hematoma, and echinococcus.

hypernephroma,
(17)

tuberculosis, pyelonephri¬

There is some debate in the litera¬

ture about medullary sponge kidney as an entity distinct from polycystic
disease.

(56)

Other pathologic processes which must be distinguished from polycystic
disease are chronic glomerulonephritis, chronic glomerulonephritis with
associated hypertension, pyonephrosis, bilateral hydronephrosis, nephropto¬
sis, and tumors and cysts in adjacent organs.

(17)

Radiographically en¬

larged, poorly functioning kidneys must also be distinguished from renal
amyloidosis, leukemic infiltration of the kidney, multiple myeloma, and
the collagen vasculidides.

TABLE 7:

1.
2.

3.
4.
5.

DIFFERENTIAL DIAGNOSIS OF CYSTIC LESIONS OF THE
KIDNEYS

Retention or inflammatory cysts
Simple cyst
a.
Single cyst
b.
Multiple cyst
c.
Multilocular cyst
d.
Hemorrhagic cyst
Peripelvic cyst
Parapelvic cyst
Pathologic cyst
a.
Calculosis
b.
Hypernephroma
c.
Echinococcus
d.
Other

after Dalgaard (17)

-
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TABLE 8:
1.
2.
3.
4.
5.
6.
7.
8.
9.

PART THREE:

DIFFERENTIAL DIAGNOSIS OF BILATERAL RENAL ENLARGEMENT

Polycystic disease
Renal neoplasm
Chronic glomerulonephritis
Bilateral hydronephrosis, pyonephrosis
Cystosis
Renal amyloidosis
Leukemic infiltration
Multiple myeloma
Collagen vascular disease

CLINICAL AND RADIOLOGICAL CORRELATIONS AND THE SIGNIFICANCE
OF THE INTRAVENOUS UROGRAM

MATERIALS AND METHODS

Recently, Lalli and Poirier (40) contended that serial intravenous
pyelography constituted a useful tool

in the evaluation of the progression

of polycystic disease and the prognostication of its clinical course.

They

based their conclusions on a sample of twenty patients drawn from the Cleve¬
land Clinic's pool of 509 cases.

TABLE 9:

Enlarged
Minimal
Enlargement
Not Enlarged
Total

[Table 9]

From this data,

they concluded

RESULTS OF SERIAL PYELOGRAPHY IN TWENTY PATIENTS WITH
POLYCYSTIC DISEASE OF THE KIDNEYS
Observation
Hema- Period (yr.)
Family
HyperNo. of
Patients History Uremia
tension Death
turia Aver.
Range
4

9

6

8

2

5

4

11

2-21

2

2

2

0
0

5

3

1

5.1
13

2-11
8-18

20

10

11

15

2

10

9.7

2-21

8

4

3

after Lalli and Poirier (40)

that correlations were made between advancing renal size and the presence
of clinical complications, and that an observed increase in renal size was
in fact correlated with the severity of the disease and could be used as an
indicator of probable shortened life expectancy.
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Chi square analysis of the data, however, leaves a less definitive
impression than this conclusion would imply.

Because of the sample size,

the data from the minimally enlarged and unenlarged groups were pooled
for interpretation.

Lalli's data are not statistically significant.

terms of the sequelae of polycystic disease, uremia
tension

[p < 0.20],

In

[p < 0.50] and hyper¬

the data do not present a valid statement of prognosis.

The increase of mortality, although not significant

[p < 0.10] is sugges¬

tive and merits further investigation of the experimental hypothesis.
Intravenous pyelography is a relatively non-invasive, benign pro¬
cedure.

Accurate prognosis on the basis of IVP would permit a more thorough

orchestration of the patient's clinical management, allowing the selec¬
tion of a compatible kidney donor while the patient is yet able to main¬
tain himself on his own diminishing renal function and before multiple
transfusions during dialysis have sensitized him to possible donor anti¬
gens.

Timely use of transplant and nephrectomy

[vide supra] would have

a salutory effect on the natural history of the disease process.
68, 69,

77,

(5,

42,

78)

The experimental population was derived from a review of the records
of ninety six cases of polycystic disease at the Yale-New Haven Hospital,
the West Haven Veteran's Administration Hospital,

the Hospital of St.

Raphael,

New Haven, Connecticut, and the Waterbury Hospital, Waterbury,

Connecticut.

Intravenous pyelograms were available on

eleven of

thirty

patients,

whom had undergone serial examinations which were still on file.

The

eleven patients had a total of thirty urograms which were examined inde¬
pendently by the author and six staff radiologists at the Yale-New Haven
Hospital.

The radiologists were asked to evaluate the parameters of

renal length and width, calyceal length and the thickness of the renal
parenchyma from the most lateral projecting calyx to the lateral margin
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of the kidney.

[Figure 2]

Names of the patients were masked, and the

examinations randomized in order to prevent comparison with a patient's
previous pyelogram.

Films for a given examination were reviewed indepen¬

dently by the six radiologists and a statistical mean drawn.

These results

were used as a standard of accuracy to gauge the reliability of the author's
assessment of the material reviewed independently.
taken from literature controls.

(54, 55, 80)

Normal values were

[See Appendix A]

trols for the length of the calyceal system were available.

No con¬

A control

group was drawn from seventy five consecutive cases performed at the YaleNew Haven Hospital from February 1 to April 23, 1974, and interpreted to
be within the range of normal by the attending staff radiologist.

[See

Appendix B]

DISCUSSION

In the evaluation of clinical history,

the cohort of thirty patients

was divided into groups according to the presence or absence of urinary
tract infection, uremia, and hypertension.

The mean lengths of the kidneys

in these groups on intravenous urography were compaired using a one tailed
"t" test; a correlation was considered statistically significant if p < 0.05.
Analysis of data indicated a statistically significant correlation between
an increased kidney length and an increased incidence of infection docu¬
mented by culture of the urine.

The longer kidney was measured and the

mean length of the kidneys in patients with infection was 18.6-2.2 cm. and
without infection, 16.3-2.8 cm.

[p < 0.025]

Thus, not only is there an

increased incidence of infection among patients with polycystic disease (79),
but that incidence increases as the kidneys enlarge.

Similar data in patients

with uremia, while not statistically significant were suggestive of a pos-

■
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Fig. 2:

Polycystic Kidney Disease — Adult Type; Assessment of Renal
Parameters.
(See text)
L= Length, W = Width, C = length of
calyceal system, P = width of renal parenchyma measured from
the lateral margin of the kidney to the most laterally pro¬
jecting calyx.

29

sible correlation between kidney length and uremia;

the mean length of

kidneys in uremic patients was 19.5-3.0 cm. and in non-uremic patients
17.2- 2.9 cm.

[p

< 0.10]

strated with hypertension;

There was no significant difference demon¬
the mean length of the kidneys in hypertensive

patients was 17.9-3.1 cm. and in normotensive patients 17.2-2.6 cm.[p < 0.30]
The data for infection may be viewed from another perspective.

TABLE 10:

[Table 10]

CORRELATION OF KIDNEY LENGTH AND URINARY TRACT
INFECTION

Kidney length (cm.)

No. of patients
with infection

No. of patients
without infection

2
5
8
15

6
4
5
15

<15
15 to 18
>18
Total

Total
8
9
13
30

The group of eleven patients for whom serial examinations were
available was broken down into groups according to the interval develop¬
ment of urinary tract infection and uremia, and the eventual development
of renal failure

[the institution of hemodialysis].

Thus, a patient mani¬

festing hypertension at the time of initial urography was eliminated from
consideration in the cohort that developed elevated blood pressures.

A

one-tailed "tn test with a value p ^.0.05 was considered significant.

The

size on the population developing interval infection and uremia [one case
each] precluded meaningful analysis.

The analysis of increasing kidney

size and hypertension was not statistically significant, a finding consis¬
tent with Lalli's data (40);

the interval change in patients developing

hypertension was 1.0-2.3 cm. and in those remaining normotensive 3.0-2.8 cm.
[p _< 0.30]

During the period of follow-up,

failure and began chronic hemodialysis.

two patients developed renal

The interval change in patients

going on to dialysis was 3.0-1.1 cm., and for the group not requiring dial-
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ysis 1.8-2.5 cm.

[p < 0.025].

Because of the small population involved,

this finding is not definitive, but merits further investigation.
This study provides statistical confirmation of the clinical im¬
pression expressed in the literature that the collecting system of the
kidneys is elongated in polycystic disease.

(7, 17)

The mean length of

the calyceal system of the right kidney was 7.1-0.9 cm.
of seventy five uninvolved patients and 10.2-2.2 cm.
thirty polycystic patients
side measured 7.2-0.9 cm.

[p <

0.01] similarly,

for the series

for the series of

the calyces of the left

and 10.4-2.8 cm., respectively.

[p < 0.01]

[Appendices A, B]
The measurements by the six staff radiologists were compared using
a "t" test to analyze the data [Appendix A] .
obtained was 1.1 cm.
0.7 cm.
system.

The precision of varian ce

for the length of the kidney, 0.7 cm. for the width,

for parenchymal width, and 1.0 cm.

for the length of the calyceal

These measurements may be applied clinically as general state¬

ments on the precision of measurement of any one event.

In this study,

they provide a guide to the precision of the author’s.
A retrospective study of hospital records is fraught with imponder¬
able variables.

Of 96 cases on record at the four institutions involved

in this study, urographic examinations were available on only 30.

Due to

problems of storage, X-rays are sent for reprocessing of silver salts
after seven years at the Yale-New Haven Hospital and after only.four years
at the Waterbury Hospital, if,

during that period, the patient has not

had further radiologic evaluation.

Patients with polycystic disease may

run a clinical course as long as thirty six years

(17) during which time

they may remain largely asymptomatic, not requiring medical assistance
with consequent removal of early examinations from their records.

Simple

loss of films is a frustrating experience with which all clinicians are
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familiar and which further compounds the problems of assembling a series
such as this.

Higgins (31) noted that during exacerbation of the disease

patients develop hematuria pain and nitrogen retention which subside during
periods of remission.

It is during these periods of active disease,

that

the patient is most likely to present to the hospital or the hospital clinic
for evaluation;

thus, in many cases, the data available from hospital records

may not be representative of the patients prevailing clinical status for
much of his course.

Assessment of the polycystic patient's data has been

on the basis of "clinical gestalt," a combination of history, physical
findings, and a laboratory evaluation which varies from physician to phy¬
sician.

A prospective evaluation is needed comparing the efficacy of

serial serum chemistry (BUN, creatinine), glomerular function (24-hour
creatinine clearance),

tubular function (PSP), urologic, and sonographic

evaluations as a means of following a patient and determining the prognosis.
A prospective study is now in progress at the Yale-New Haven Hospital in
which polycystic patients and their families are being evaluated sonographically.

SUMMARY
Thirty patients with polycystic disease of the kidney were studied.
A radiologic sign of increased length of the calyceal system in the kid¬
neys of patients with the disease over normal was described.

Correlations

of the clinical course of the disease and increased kidney length were
made.

There is a statistically significant correlation between the inci¬

dence of urinary tract infection and the increased length of the kidney.
No such correlations were found for hypertension or uremia.

Analysis of

interval changes in kidney length in eleven patients with serial examina¬
tions, revealed a significant correlation between an interval change of
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3.0 cm. on diagnostic urograms and the development of renal failure.

The

data did not support an association of the development of hypertension with
increasing kidney length.
Twenty nine intravenous pyelograms were examined by six staff radi¬
ologists of the Yale-New Haven Hospital.

They were asked to measure the

length of the calyceal system on each kidney on each examination.
cisions of variance obtained when this was analyzed were:1
Width =0.7 cm.; parenchymal thickness =0.7 cm.; and,
1.0 cm.

The pre¬

length = 1.1 cm.

calyceal length =

These values may be used by the clinician as a guide to the pre¬

cision of measurement of a urogram by a radiologist on any one occasion.
This study constitutes a necessary preamble to a study, now in
progress, comparing the efficacy of intravenous pyelography and ultrasound
in the investigation of polycystic disease.

In order to evaluate the con¬

tributions available from ultrasonic investigation, it was necessary to
define the limits of the currently accepted evaluative tool, intravenous
urography.
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APPENDIX A

RADIOGRAPHIC MEASUREMENTS * OF NORMAL KIDNEYS
Vourinen
(80)

Moell 1956
(55)

Moell 1961
(54)

Right Kidney
Length
Width

12.7 J 0.78
6.3 - 0.49

12.9 J 0.80
6.2 - 0.45

“f*
12.4 t 1-02
6.2 - 0.72

Left Kidney
Length
Width

13.2 | 0.82
6.4 - 0.55

13.2 | 0.79
6.3 - 0.49

12.7 i 1.12
6.2 - 0.45

Right Kidney
Length
Width

12.4 £ 0.66
5.9 - 0.37

12.3 | 0.79
5.7 - 0.46

12.0 X 1.08
5.7 - 0.56

Left Kidney
Length
Width

12.8 | 0.77
6.1 - 0.38

12.6
0. 77
5.9 - 0.42

12.5 | 1.29
6.2 - 0.61

MEN

WOMEN

* all measurements in cm.

± 1 S. D.
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RESULTS OF SERIAL PYELOGRAPHY IN ELEVEN PATIENTS AS READ BY SIX STAFF
RADIOLOGISTS AT THE YALE-NEW HAVEN HOSPITAL

LEFT KIDNEY*

Length

Patient
M.. B.
S.,C.
C., D.

F., D.
G., G.

G. J.

+

15.
14.
18.
18.
15.
16.
16.
18.

2 i 0.2
T
7 X 0.3
i
6 JL 0.4
i
4 4* 0.2
T
9 4- 0.5+
i
8
0.5+
6 4- 0.4
i
1
1.1

16.
16.
14.
15.
14.

7

J.,M.
A.,M.
G.,S.
M., T.

4.
T
1
4“

5

4T
1
4“
t

T

4.
1
41

18. 1 1
-r
20. 9 1
T
20. 5
+
20. 4 4.
»
18. 7
+
18. 1 4.
1
14. 9
+
15. 8 I
l
17. 5
+
19. 1
16. 1**
7**

O
-0. 5/ 2/12 yr.
-0. 2/ 3/12 yr.

+0. 7/
3i¥! yr.
+1. 5/
4io/12
+2. 2/ 710/121 yr.
-0. 2/ 3/12 yr.
1

0. 4

8

16. 3
17. 8
17. 1

16.

0.5
1. 9

1**
1**

21. 0
C.,L.

Interval Change
in Length

0.7
0.3
1.2
1.0
2.3
1. 3
0.5
2.0
1.0
0.1
0.3
0.3
1.4
2.1

+1. 0/ 3J/12 yr.
-0. 3/10^/12 yr.
+0. 7/13/12 yr.
O

+1. 9/ 17/12 yr.
-1. 1/ 37/12 yr.
+0. 8/ 5/12 yr.
+3. 9 :1/12 yr.
+4. 7/ 6/12 yr.
+2. 8/

712 yr.
7

-0.

1/ 3/12 yr.

-0. 6/
+0. 9/
+1.
-3.
-1.
+0.
-0.

4/12 yr.
712 yr.

6/
/12 yr.
yr.
0/
1R/12
4/ i;/i2 yr.
6/
yr.
8/ 2/12 yr.

Calyceal
Length

Width
+
6..4
1.,0
•7.,4 4- 0.,4
9,.4 4_ 0., 4
1
9., 8
0..9
+
,
6
6.
4- 0.,4
T
6.,0 4- 0.,3
1
6..8 4- 1.,0
1
0.,4
7.,0
4T

10.,6

4i .
1
T
.J.
*r

4T

41

8.,4 l
8.,5
9., 0**
jr
8..4 1
4"
9.,2
4"
9.,0 i
4"
8.,0
+
8,.1 1
4*
8.,5
47..8
7.,5**

+
+

+
+
+
+
10.6
+

1.2
0.6
0.5
0.9
1.7
0.4

9.4
1.0
+
9.9
0.5

+

0.6
2.5
+
0.7
2.7
+
0.2
3.0
+
0.2
2.8
+
2.6
1.8
+
0.4
3.1
3.3 ±0.8
2.7 ± 1.1

9.0 ±1.2
10.3 - 0.9
7.5**
7.0**
8.7 ± 0.7

3.2 - 0.2
3.0 - 0.0
2.5**

0.,9
0..6
0.,5

12.8 - 0.3
13.1 ± 0.5

12.6 ± 1.2

3.7 - 0.9
2.3 x 0.6
2.7 ± 0.5

0.,9

12.4 - 1.4

2.9 ± 0.6

1,.0
0., 6

12.0 ± 0.8

3.0 - 0.6
2.5 ±0.5
4.4 - 0.2
2.6 - 1.4
2.8 - 0.7
4.5**
2.3 - 0.5

9.,4 1 0., 6
T
8., 6
0., 6
8.,0**
7..3**
8.,0 - 0..4
9.,5
9., 6
9.,6

9.7
9.6
12.3
11.6
9.5

Parenchymal
Width

0.,7
0., 5
0.,1
0.,6
0..2
0., 6
0.,3

7., 9**

11.8 ± 0.3
16.0 - 0.6
11.7 - 3.9
12.7 - 0.5
13.3 - 0.6

8.2

-

0.6

3.0 ± 0.7

8.9 - 1.1
11.9 - 0.2
11.7**

2.8

-

0.4

2.8

-

0.2

11.0**

2.7**

* all measurements in centimeters - 1 S.D.
** read by only radiologist
+ performed during same hospital admission;
an intravenous pyelogram,

the first examination is

the second a tomogram
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RIGHT KIDNEY*

Patient

M.B.
S.C.
C.D.

F.D.
G.G.

G. J.

Length

15.5 J 0.8
14.0 ± 0.5
19.4 J 0.7
21.6 ± 0.5
12.0+**
12.4+**
10.7 ~ 0.4
13.0 - 0.9
4*
13.8 - 0.5
15.8 - 1.3
13.6**
14.5**
15.4 ± 0.5
4
16.5 ~ 1.8
18.2 J 0.7
19.0 - 3.2
19.4 - 0.2

C.L.
A.M.
J.M.
G.S.
M.T.

17.8 - 1.0

24.9 l
20.3 J
17.6 J
20.6 J
20.2 14.3 ?
15.2 14.0 J
14.2 14.0**
14.3**

0.9
3.2
0.6
0.8
2.0
0.4
0.6
0.0
0.6

Interval Change
in Length

-1.5 2/12 yr.
A

+2,2/ 3/12 yr.

Width

0.3
6-7
7.2 -+ 0.2
8-7 5 0.3
8.4 - 0.7

Calyceal
Length

Parenchymal
Width

8.7 i 1.0
0.7

2.2 J 0.4
2.2 - 0.4
0.6

1.6

0.7

iS:f i

*

13.0

0.2

7.5**
6.0**

3‘1 +
3.9 3.6**
2* 7 J
2.5 2.9 -

0.3

-1.3/ 3 gr.
+2.3/ 4^/12 yr.
+0.6/ 7/12 yr.

8.0 - 1.3
7.7 Z 0.2

f)

8.5 - 0.3
8.3 - 0.9
6/7**
6.2**
6.7 - 0.2

0.7
8.4 - 0.5
7.5**
7.5**
8.7 - 0.2

3.0**
2.5**
2.4 - 0.4

4.
9.7 - 0.5
9.3 t 1.1
9.1 - 0.7

9.5**
11.3 J 0.4
1.0
13.4

3.0 ± 0.1
2.9 ± 0.6
3.2 ± 0.7

IQ. 3 - 1.2

uJ 0.2

2.6 - 0.3

+2.0/ 3/12 yr.
1

+0.9/ 3^/12 yr.
+0.9/10^/12 yr.
+1.8/13/12 yr.
o
+1.7/ i;/12 yr.
+0.8/ 3J /12 yr.
+2.5/ 57/12 yr.
+0.4/ H/12 yr.
+2.9/ 6/12 yr.

•J
+7.1/ 7/12 yr.
A
-2.7/ 712 yr.

•J
-0.4/ 3 /12 yr.
+0.9/ 4/12 yr.
+0.2/ 712 yr.
-0.2/ 1712 yr.
0.0/ 1/12 yr.
+0.3/ 1712 yr.
+0.1/ 2/12 yr.

4-

7.8
9.1
8.9
9.1
9.5

6.7 - 0.7
4-

7'9 +

l 0.3

10.1 J 0.7

0.8
0.5
0.3
0.0
0.6
0.0
0.9
0.5
0.3

10.3 J 2.1

+
^
-

8*5 +
7.0 7*4 +
7.9 8.0 ±
8.3**
8.0**

11.2
11-2
13.3
13.7
8.7

J 0.4
+ 1.5
- 1.0
| 1.2
- 0.3

8.2 J 0.4
7.5 ± 0.5
8.3**
8.3**

0.0

0.3

+

2.8 - 0.3
2.8 - 0.5

3*° J
3.2 |
2.8 t
3.8 4.0 l
3-4 l
2.2 4.5**
3.0 2.7 t

2.5**

* all measurements in centimeters - 1 S.D.
+ performed during same hospital admission; the first examination is
an intravenous pyelogram, the second a tomogram
** read by only one radiologist

0.4
0.6
1.5
1.2
1.3
0.9
0.4
0.3
0.3
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RESULTS OF SERIAL PYELOGRAPHY IN ELEVEN PATIENTS AS READ BY SIX
STAFF RADIOLOGISTS AT THE YALE-NEW HAVEN HOSPITAL:
PRECISION OF VARIABILITY***

Length

Width

Calyceal
Length

Right kidney

+ 1.1

± °*7

+ 0.9

Left kidney

+ 1.1

+ 0.7

± 1>1

*** measurements in centimeters

Parenchymal
Width

+ 0.7
+ 0.7
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FIGURE 1= COMPARATIVE MEASUREMENTS OF KIDNEY LENGTH

AUTHOR

0

SIX STAFF RADIOLOGISTS

LEGEND
-range of variability
•
LEFT KIDNEY
•
RIGHT KIDNEY

o
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FIGURE 2:

COMPARATIVE

MEASUREMENTS OF KIDNEY

author

WIDTH

SIX STAFF RADIOLOGISTS

LEGEND
-

- RANGE OF VARIABILITY
•

LEFT KIDNEY

°

RIGHT KIDNEY

FIGURE 3: COMPARATIVE

MEASURENTS

OF RENAL

AUTHOR

PARENCHYMAL WIDTH

legend
—

range of Variability

•

LEFT KIDNEY

°

RIGHT KIDNEY
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FIGURE 4: COMPARATIVE MEASUREMENT OF RENAL
LENGTH

AUTHOR

CALYCEAL

SIX STAFF RADIOLOGISTS

LEGEND
range of variability

•

LEFT KIDNEY

®

RIGHT KIDNEY

APPENDIX B

INDICATIONS FOR INVESTIGATION IN SEVENTY FIVE PATIENTS WITH NORMAL
INTRAVENOUS PYELOGRAMS

Indication on Radiology Requisition

Number of Cases
17
13
8
7
5
4
4
4
3
2
2
1
1
1
1
1
1

Hypertension
Recurrent urinary tract infection
Hematuria
Flank or back pain
Benign hypertrophy of the prostata
Ureteral colic
Fever of unknown origin
Diabetes Mellitus
Carcinoma of the cervix
Diverticulosis
Pancreatitis
Crohn's disease
Tuberculosis
Carcinoma of the breast
Mycosis fungoides
Kidney donor
Testicular pain

CALYCEAL LENGTH IN NORMAL KIDNEYS *

Right kidney

Men
7.3 - 0.80

Women
6.8 - 0.84

Total
7.1 - 0.87

Left kidney

7.4 - 0.86

7.0 - 0.84

7.2 - 0.87

* all measurements in cm. + 1 S. D.
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